Ireland
--:--IST
Recruiting Not applicable

Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion

NCT07407946 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2026-02-23
Last updated
2026-02-27

Condition(s) studied

Post-traumatic Stress Disorder (PTSD)

Investigational drug(s) / intervention(s)

Blended Trauma-Focused Cognitive Behavioral Therapy with Compassion (bTF-CBT-C)Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)

Blended Trauma-Focused Cognitive Behavioral Therapy with Compassion (bTF-CBT-C): Blended trauma-focused cognitive behavioral therapy with integrated compassion-focused strategies, combining therapist-led videoconferencing and selected in-person sessions with self-paced app-based modules. The intervention includes an initial introduction and safety planning, a stabilization phase with digital psychoeducation and compassion-based emotion regulation skills, therapist-led trauma narrative and cognitive processing, and a recovery phase focusing on in vivo mastery, caregiver-adolescent conjoint work, and relapse prevention. Caregivers participate throughout treatment, including parallel app-based modules during stabilization and selected therapist-led sessions.

Trauma-Focused Cognitive Behavioral Therapy (TF-CBT): Standard trauma-focused cognitive behavioral therapy delivered face-to-face in routine child and adolescent psychiatric care. Treatment follows the TF-CBT PRACTICE components, including psychoeducation, affect regulation, cognitive coping, trauma narrative and processing, in vivo exposure, conjoint caregiver-adolescent sessions, and safety planning, with caregiver involvement according to the TF-CBT manual.

Study summary

Brief Summary

The goal of this clinical trial is to evaluate the feasibility and acceptability of a blended (mHealth) Trauma-Focused Cognitive Behavioral Therapy with Compassion (bTF-CBT-C) for adolescents with post-traumatic stress disorder (PTSD) in routine child and adolescent psychiatric services in northern Sweden. The main questions it aims to answer are:

* Is bTF-CBT-C feasible to deliver in routine care, as indicated by recruitment, retention, adherence to sessions and app modules, data completeness, and adverse events?
* Is bTF-CBT-C acceptable to adolescents, caregivers, and therapists, as indicated by satisfaction, therapeutic alliance, digital treatment evaluation, and qualitative interviews? Researchers will compare bTF-CBT-C to standard TF-CBT to explore whether the blended format shows similar or potentially improved patterns in clinical outcomes (e.g., PTSD symptoms, emotion regulation, and self-compassion) and to estimate variability needed to plan a future non-inferiority trial.

Participants will:

* Complete eligibility screening and baseline assessments, including a diagnostic interview for PTSD.
* Be randomized to either bTF-CBT-C or standard TF-CBT.
* Receive trauma-focused treatment over time, with caregiver involvement in both groups.
* In the bTF-CBT-C group, use a secure mobile app for stabilization modules and exercises, together with therapist-led video sessions and selected in-person meetings.
* Complete assessments at baseline, after stabilization, post-treatment, and at 6-month follow-up, and provide feedback about their experiences (questionnaires and interviews).

Eligibility

Sex
ALL
Min age
12 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Adolescents aged 12-17 years. * Meet DSM-5 criteria for post-traumatic stress disorder (PTSD) confirmed by diagnostic interview (MINI-KID). * Score ≥25 on the Child and Adolescent Trauma Screen (CATS-2) at baseline. * Receiving care within routine child and adolescent psychiatric services in participating regions. * Have a non-offending caregiver willing and able to participate in caregiver components of treatment. * Able to communicate in Swedish sufficiently to engage in treatment and assessments. * Provide informed assent/consent, with caregiver consent according to age and regulations. Exclusion Criteria: * Acute suicidality or risk requiring inpatient care. * Active psychotic disorder or severe dissociative symptoms that interfere with participation. * Autism spectrum disorder, severe eating disorder, or obsessive-compulsive disorder requiring primary specialized treatment. * Ongoing trauma exposure or unstable living conditions that would prevent safe participation. * Cognitive impairment or medical condition that precludes participation in psychotherapy or digital components. * Substance use disorder requiring treatment, or regular use of benzodiazepines (\> once per week). * Concurrent trauma-focused psychotherapy or recent initiation/discontinuation of psychotropic medication (within the past 6 weeks), or planned medication changes during the study period.

Primary outcome measure(s)

  • Recruitment rate — Baseline (enrollment, day 1)
    Proportion of eligible adolescents who consent to participate.
  • Retention Rate — Baseline (day 1), poststabilization (completion after an average of 5 weeks), post-treatment (study completion up to 25 weeks) up to 6 months
    Proportion of enrolled participants completing post-stabilization, post-treatment, and 6-month follow-up assessments.
  • Adherence to Treatment Components — Post-stabilization (an average of 5 weeks) and post-treatment (study completion up to 25 weeks).
    Adherence will be assessed as (1) the number of therapist-led sessions attended out of the planned total, and (2) the number of app-based modules (C0-C9) completed. Higher numbers reflect higher adherence.
  • Adverse Events — From baseline through treatment completion (up to 25 weeks) to 6 months follow up after study completion.
    Number and type of adverse events reported during the intervention.
  • Acceptability and User Experience (Qualitative Interviews) — Through study completion, up to 6 month follow up.
    Semi-structured qualitative interviews will explore overall acceptability, perceived helpfulness, usability, burden, and user experience of the blended TF-CBT with compassion.

Trial sites (1)

FacilityCityRegionStatus
Umeå University, Clinical Science, Child- and Adolescent Psychiatry Umeå Sweden Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07407946 on ClinicalTrials.gov ↗ ← All trials in Sweden